Trademark Overview
On Thursday, July 10, 2025, a trademark application was filed for XGENERA with the United States Patent and Trademark Office. The USPTO has given the XGENERA trademark a serial number of 79433300. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, July 8, 2026. This trademark is owned by Xgenera Ltd. The XGENERA trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer and pre-cancerous conditions, cardiovascular and cerebrovascular diseases, neurological and neurodegenerative diseases, infectious diseases, inflammatory and autoimmune diseases, metabolic and endocrine diseases, respiratory disease, renal and urological diseases, reproductive related conditions; chemical preparations for testing blood for medical purposes; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; reagents for use in medical testing; diagnostic testing materials for medical use; medical diagnostic test strips for use in the field of oncology, cardiology, neurology, infectious disease, immunology, endocrinology, respiratory medicine, nephrology urology and obstetrics; medical diagnostic reagents; medical testing kits comprised of medical diagnostic reagents and assays ...
Medical testing services; medical analysis services for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing and medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; medical testing services for blood and urine testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, analysis of human blood, urine, tissue and cells for medical treatment and diagnostics; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, RNA or DNA analysis services for cancer diagnosis and prognosis; medical laboratory services for the analysis of samples taken from patients relating to the treatment of persons
Medical testing instruments and apparatus, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; apparatus and instruments for use in medical analysis, namely, for detecting and measuring analytes in biofluids; testing probes and testing apparatus for medical diagnostic purposes, namely, medical diagnostic apparatus for testing cancer cells, human blood, urine, tissue, and biofluids; apparatus for DNA and RNA testing for medical purposes; diagnostic instruments for medical use, namely, medical diagnostic apparatus for testing biomarkers; medical test kits for identifying oncological, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, immune system related infection and disease; medical test kits for diagnostic cancer and pre-cancerous conditions, ca...
